Clinical Trial Update: Obeticholic Acid for Prevention in Barrett's Esophagus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating obeticholic acid for prevention in Barrett's Esophagus, with recruitment ongoing and potential relevance to Esophageal Ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus, Esophageal Adenocarcinoma | Phase 2 | Status: RECRUITING